menu
아주대학교 의학문헌정보센터
검색
All
Title
Author
Keyword / MeSH
Year
Journal Title
Contains
Equals
repository
BROWSE
Communities & Collections
AJOU Authors
Title
Publication Year
Keyword
Keyword (Historical Materials)
Journal
AJOU Open Repository
Browsing "Hematology-Oncology" by Journal : Annals of oncology
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
가
나
다
라
마
바
사
아
자
차
카
타
파
하
All
가
나
다
라
마
바
사
아
자
차
카
타
파
하
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Sort by:
title
Publication Year
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 1 to 7 of 7
Pub Year
Title
Author(s)
2019
Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial
이현우
2020
Clinical outcomes of early-progressed follicular lymphoma in Korea: A multicenter, retrospective analysis
최윤석
2018
Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy
강석윤
2019
EndoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment
강석윤
2013
Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients.
박준성
2013
Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905).
강석윤
2022
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy
권민석
1
Browse
Communities & Collections
Ajou Authors
Titles
Publication Year
Keyword
Journal
Guide
아주대학교 의학문헌정보센터
